Right now, the HALT Study is underway to provide the substantial evidence of effectiveness necessary for the full FDA approval of Felycin-CA1 (referred to as TRIV202 in HALT) for the management of ...
Your heart is a muscle. As Dr. Noah Moss, an advanced heart failure and transplant cardiologist at the Mount Sinai Fuster Hospital in New York City, puts it, “a very special muscle, but a muscle.” ...
Correspondence to Dr Jonathan A Drezner, Department of Family Medicine, Sports Medicine Section, University of Washington, Seattle, WA 98195-0005, USA; jdrezner{at}uw.edu Objectives We assessed ...
Hypertrophic Cardiomyopathy (HCM) affects an estimated 600,000 Americans each year—and claims the lives of roughly 6,000 of them—as the most common genetic heart defect and most frequent cause of ...
Heart disease became a very personal issue for me this past year. My story is probably similar to many women with heart disease, but hopefully will serve as a warning for some. In June 2017, I was ...
At 16, Sara Dumas learned she needed a new heart. Brother also afflicted. July 15, 2010— -- When she was four, Sara Dumas' parents took her to the emergency room. The girl had been vomiting ...
Hypertrophic cardiomyopathy (HCM) is an underdiagnosed genetic heart condition. Raising awareness through advocacy can help increase the rates of diagnosis and proper management. HCM is when the left ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback